Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

This study is ongoing, but not recruiting participants.

Sponsor:

ClinicalTrials.gov Identifier:

NCT01409915

First Posted: August 4, 2011

Last Update Posted: May 24, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborator:

The Dana Foundation

Information provided by (Responsible Party):

University of Colorado, Denver

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2017
Estimated Primary Completion Date:	November 2017 (Final data collection date for primary outcome measure)

Study Status:

This study is ongoing, but not recruiting participants.

Estimated Study Completion Date:

December 2017

Estimated Primary Completion Date:

November 2017 (Final data collection date for primary outcome measure)